Clinic «REFRESH»
Book a consultation
Book
area-icon
Dubai
English
menu_item_arrow
10:00 – 21:00 Sunday is a day off
Retatrutide Pen is an advanced format of a triple metabolic agonist that simultaneously activates three key energy-regulation receptors: GLP-1, GIP, and the glucagon receptor (GCGR). This combined mechanism enhances appetite contr...
Retatrutide Pen is an advanced format of a triple metabolic agonist that simultaneously activates three key energy-regulation receptors: GLP-1, GIP, and the glucagon receptor (GCGR). This combined mechanism enhances appetite control, increases energy expenditure, and optimizes nutrient partitioning.

Clinical data show that Retatrutide can achieve up to 24% body-weight reduction per treatment course, positioning it as one of the most promising next-generation agents for metabolic programs.

The pen format ensures precise dosing, ease of use, and a stable pharmacological profile suitable both for appetite management and for comprehensive body-recomposition protocols.

Properties & Effects of Retatrutide

• pronounced appetite reduction via GLP-1 and GIP activation
• enhanced lipolysis and increased energy expenditure through GCGR stimulation
• improved glycemic control and higher insulin sensitivity
• better lipid profile and reduced visceral fat
• increased metabolic flexibility and resilience to stressors
• supports endurance and helps preserve lean mass during weight reduction

Reasons to Сhoose Retatrutide

• one of the most potent metabolic agonists of the new generation
• highly effective for BMI >30 and for cases resistant to other therapies
• triple-mechanism action: appetite suppression, metabolic regulation, energy expenditure
• clinically noticeable improvements within the first weeks
• suitable for long-term weight-management and appetite-control programs

Period

Commonly Used Range

Weeks 1–4

1–2 mg or 2 mg once weekly

Weeks 5–8

4 mg once weekly

Weeks 9–12

6 mg, sometimes 8 mg once weekly

Weeks 13–16

8 mg or higher based on tolerance

Further

8–12 mg as a working range in many protocols

Retatrutide Administration and Dosage


Subcutaneously once a week (abdomen/thigh), starting with 1–2 mg, titrating up to 8–12 mg.
Course duration: 6–12 months under medical supervision with weight/glucose monitoring.
Storage conditions: 2–8°C, after opening — up to 28 days at room temperature.

Effects
Weight loss: 17–24% per year (Phase 3 trials results).
Appetite reduction: by 30–50%, stabilization of glucose levels.
Metabolism boost: increased energy expenditure, visceral fat reduction by 40%.
Retatrutide Pen is a revolutionary tool for sustainable weight loss with triple metabolic effect and high convenience.



Retatrutide Pen is ideal for individuals seeking significant weight reduction, metabolic optimization, and stable appetite regulation. It fits seamlessly into body-recomposition protocols, anti-stress metabolic programs, and long-term maintenance systems.